Breast Cancer Symposium 2024

Permian Basin Breast Cancer Symposium 2024

Date: Friday, October 25, 2024
Time: 8:30 AM - 5:00 PM
Location: TTUHSC Odessa Campus - Academic Classroom Building Community Room
321 Dotsy Ave.
Odessa, TX 79763

Conference Summary

There is a lack of comprehensive and up-to-date information on the latest advancements in breast cancer diagnosis, treatment, and management. Healthcare professionals attending the symposium may not have access to the most current research findings, emerging technologies, and best practices in the field of breast cancer care. This hinders the ability to provide optimal care to patients and may result in suboptimal outcomes. Through targeted educational sessions and interactive discussions, the symposium aims to equip attendees with necessary tools and knowledge to enhance their clinical practice and improve patient care in the realm of breast cancer.

TARGET AUDIENCE:

Physicians, Nurses, & Pharmacists

Upon completion of this conference, the attendees should be able to:

Evaluate and apply best practices in the field of breast cancer care, demonstrating an understanding of how these practices can lead to improved patient outcomes and enhanced quality of care.
Develop personalized care plans for patients with breast cancer, integrating the knowledge and tools acquired during the educational sessions to provide optimal and up-to-date care in line with current standards and guidelines.
Summarize the latest advancements in breast cancer diagnosis, treatment, and management, incorporating evidence-based research findings and emerging technologies into their practice.

View our 2024 Breast Cancer Symposium Sponsors

Accrediation and Designation

In support of improving patient care, this activity has been planned and implemented by Texas Tech University Health Sciences Center and University Medical Center Health System. Texas Tech University Health Sciences Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 6.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

Texas Tech University Health Sciences Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Texas Tech University Health Sciences Center designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity

DISCLOSURE & MITIGATION OF RELEVANT FINANCIAL RELATIONSHIPS:

It is the policy of Texas Tech University Health Sciences Center Office of Continuing Medical Education to abide by the ACCME Standards for Integrity and Independence in Accredited Continuing Education. It is the policy of TTUHSC to collect information from all planners, faculty, and others in control of educational content about all their financial relationships with ineligible companies within the past 24 months and mitigate relationships prior to the individuals assuming their roles. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Governmental agencies and providers of direct patient care services are not considered to be ineligible companies.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. TTUHSC expects that the content or format of an accredited continuing education and related materials will promote improvements in quality of healthcare and not the specific proprietary business interest of an ineligible company. We employ several strategies to ensure the absence of commercial bias and mitigate relevant financial relationships. None of the planners or faculty for this educational activity have relevant financial relationships to disclose with ineligible companies.